strong>READ MORE:
• A2 Milk boosts annual net profit by 34%, Covid a 'modest positive'
• Premium - A2 Milk's biggest problem - what to do with a mountain of cash
• Premium - How a2 Milk remained unscathed by the coronavirus outbreak
• Premium - Big Read: A2 Milk - formula for growth
Chief executive Geoff Babidge said a2 Milk had been asssessing participation in manufacturing capacity and capability because of the increasing scale of its infant nutrition business.
"The potential investment in Mataura Valley Milk's recently commissioned facility, alongside China Animal Husbandry Group, aligns with this strategic objective as we look to complement and build upon our current strategic relationships with Synlait Milk and Fonterra Co-operative Group, which remain in place," he said.
A2 Milk plans to nnvest further to establish blending and canning capacity at Mataura's facility to support setting up a fully integrated manufacturing plant for infant nutrition.
Discussions with MVM were "ongoing and remain incomplete".
Any transaction that results from the current discussions is expected to be settled towards the end of a2 Milk's cash reserves.
At its annual result this week, a2 Milk said its cash balance was $854m.
The move appeared to have the blessing of Synlait Milk, which exclusively makes formula for a2 Milk and which is part owned by the company.
Synlait said it had a "long-standing, strong and complementary partnership" with a2 Milk.
"It is a partnership that continues to strengthen as both companies grow together," Synlait said.
"Synlait is well positioned to continue to support and enable a2 Milk's rowth aspirations via its highly integrated infant formula manufacturing capabilities that meet the high standards in China - the world's largest infant nutrition market," it said.